Evidence to support the cellular mechanism involved in serum IgG homeostasis in humans.

IgG is the most abundant serum antibody and is an essential component of the humoral immune response. It is known that the 'neonatal' Fc receptor (FcRn) plays a role in maintaining constant serum IgG levels by acting as a protective receptor which binds and salvages IgG from degradation. However, the cellular mechanism that is involved in serum IgG homeostasis is poorly understood. In the current study we address this issue by analyzing the intracellular fate in human endothelial cells of IgG molecules which bind with different affinities to FcRn. The studies show that IgG which do not bind to FcRn accumulate in the lysosomal pathway, providing a cellular explanation for short serum persistence of such antibodies. We have also investigated the saturability of the homeostatic system and find that it has limited capacity. Our observations have direct relevance to the understanding and treatment of IgG deficiency, and to the effective application of therapeutic antibodies.

[1]  Richard G. W. Anderson,et al.  Reversible accumulation of cholesteryl esters in macrophages incubated with acetylated lipoproteins , 1979, The Journal of cell biology.

[2]  B. Ober,et al.  The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. , 1996, Molecular immunology.

[3]  Raimund J. Ober,et al.  Increasing the serum persistence of an IgG fragment by random mutagenesis , 1997, Nature Biotechnology.

[4]  C. Anderson,et al.  The protection receptor for IgG catabolism is the beta2-microglobulin-containing neonatal intestinal transport receptor. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[5]  N. Copeland,et al.  Mouse MHC class I-like Fc receptor encoded outside the MHC. , 1993, Journal of immunology.

[6]  G. Winter,et al.  Antibody framework residues affecting the conformation of the hypervariable loops. , 1992, Journal of molecular biology.

[7]  R. Ober,et al.  Differences in promiscuity for antibody-FcRn interactions across species: implications for therapeutic antibodies. , 2001, International immunology.

[8]  W. Lencer,et al.  Functional Reconstitution of Human FcRn in Madin-Darby Canine Kidney Cells Requires Co-expressed Human β2-Microglobulin* , 2002, The Journal of Biological Chemistry.

[9]  S L Morrison,et al.  Analysis of the pH dependence of the neonatal Fc receptor/immunoglobulin G interaction using antibody and receptor variants. , 1995, Biochemistry.

[10]  A. Rees,et al.  Isolation and characterization of an Fc receptor from neonatal rat small intestine , 1985, European journal of immunology.

[11]  D. Schoenfeld,et al.  Increased clearance of IgG in mice that lack β2‐microglobulin: possible protective role of FcRn , 1996, Immunology.

[12]  M. Urist,et al.  Phase I trial of the murine monoclonal anti-GD2 antibody 14G2a in metastatic melanoma. , 1992, Cancer research.

[13]  Jin‐Kyoo Kim,et al.  Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor , 1994, European journal of immunology.

[14]  Esther Jacobowitz Israel,et al.  Requirement for a beta 2-microglobulin-associated Fc receptor for acquisition of maternal IgG by fetal and neonatal mice. , 1995, Journal of immunology.

[15]  S. Mayor,et al.  Sorting of membrane components from endosomes and subsequent recycling to the cell surface occurs by a bulk flow process , 1993, The Journal of cell biology.

[16]  S. Morrison,et al.  The use of severe combined immunodeficiency mice to study the metabolism of human immunoglobulin g , 1994, Cancer.

[17]  I. Ellinger,et al.  IgG transport across trophoblast‐derived BeWo cells: a model system to study IgG transport in the placenta , 1999, European journal of immunology.

[18]  N. Simister,et al.  Bidirectional transcytosis of IgG by the rat neonatal Fc receptor expressed in a rat kidney cell line: a system to study protein transport across epithelia. , 2000, Journal of cell science.

[19]  R. Ober,et al.  The MHC class I-related receptor, FcRn, plays an essential role in the maternofetal transfer of gamma-globulin in humans. , 2001, International immunology.

[20]  H. Broly,et al.  Use of hu-IgG-SCID mice to evaluate the in vivo stability of human monoclonal IgG antibodies. , 1994, Journal of immunological methods.

[21]  Jin‐Kyoo Kim,et al.  Localization of the site of the IgG molecule that regulates maternofetal transmission in mice , 1996, European journal of immunology.

[22]  Pamela J. Bjorkman,et al.  Crystal structure of the complex of rat neonatal Fc receptor with Fc , 1994, Nature.

[23]  B. M. Eaton,et al.  Uptake and fate of exogenous immunoglobulin G in the perfused human placenta. , 1983, Journal of reproductive immunology.

[24]  F. Maxfield,et al.  Quantification of low density lipoprotein and transferrin endocytic sorting HEp2 cells using confocal microscopy. , 1994, Journal of cell science.

[25]  M. Brown,et al.  The scavenger cell pathway for lipoprotein degradation: specificity of the binding site that mediates the uptake of negatively-charged LDL by macrophages. , 1980, Journal of supramolecular structure.

[26]  Jin‐Kyoo Kim,et al.  Mapping the site on human IgG for binding of the MHC class I‐related receptor, FcRn , 1999, European journal of immunology.

[27]  A. West,et al.  Crystal structure at 2.8 A of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. , 2001, Molecular cell.

[28]  A. Lefvert,et al.  Pharmacokinetics of the mouse monoclonal antibody 17-1A in cancer patients receiving various treatment schedules. , 1990, Cancer research.

[29]  Jin‐Kyoo Kim,et al.  Abnormally short serum half‐lives of IgG in β2‐microglobulin‐deficient mice , 1996, European journal of immunology.

[30]  M. Simionescu,et al.  Functional expression of the MHC class I-related receptor, FcRn, in endothelial cells of mice. , 1998, International immunology.

[31]  E. Ward,et al.  Multiple roles for the major histocompatibility complex class I- related receptor FcRn. , 2000, Annual review of immunology.

[32]  E. Ward,et al.  FcRn: the MHC class I-related receptor that is more than an IgG transporter. , 1997, Immunology today.

[33]  E. Ward,et al.  Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. , 1997, Journal of immunology.

[34]  C. Story,et al.  A major histocompatibility complex class I-like Fc receptor cloned from human placenta: possible role in transfer of immunoglobulin G from mother to fetus , 1994, The Journal of experimental medicine.

[35]  J. Kraehenbuhl,et al.  Receptor-mediated transport of IgG , 1984, The Journal of cell biology.

[36]  J. Uhr,et al.  The antitumor activity of an anti-CD22 immunotoxin in SCID mice with disseminated Daudi lymphoma is enhanced by either an anti-CD19 antibody or an anti-CD19 immunotoxin. , 1992, Blood.

[37]  R. Jaenisch,et al.  β2-Microglobulin deficient mice lack CD4−8+ cytolytic T cells , 1990, Nature.

[38]  E. Ward,et al.  Abnormally short serum half-lives of IgG in beta 2-microglobulin-deficient mice. , 1996, European journal of immunology.

[39]  Leonard G. Presta,et al.  High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR* , 2001, The Journal of Biological Chemistry.

[40]  F. W. R. BRAMBELL,et al.  A Theoretical Model of γ-Globulin Catabolism , 1964, Nature.

[41]  I. Ellinger,et al.  Intracellular traffic of the MHC class I-like IgG Fc receptor, FcRn, expressed in epithelial MDCK cells. , 1999, Journal of cell science.

[42]  M. Simionescu,et al.  Expression of functionally active FcRn and the differentiated bidirectional transport of IgG in human placental endothelial cells. , 2001, Human immunology.

[43]  P. Bjorkman,et al.  Investigation of the interaction between the class I MHC-related Fc receptor and its immunoglobulin G ligand. , 1994, Immunity.

[44]  W Strober,et al.  Metabolism of immunoglobulins. , 1969, Progress in allergy.